Health

Positron Emission Tomography (PET) or inte-grated PET/Computed Tomography (PET/CT) with 18F-Fluoro-Deoxy-Glucose (18F-FDG) is a fu-nctional imaging modality, useful in the char-acterization of undetermined morphological fin-dings, and in the staging/re-staging of a large number of malignancies. Although its use in uterine malignancies has been poorly investi-gated, in recent years the employment of this technique has constantly increased. In this re-view, we evaluate the role of PET (/CT) with 18F-FDG in uterine malignancies (cervical and en-dometrial cancers as well as uterine sarcomas), underlying its advantages and discussing its limitations. Metabolic and anatomic information given by PET/CT with 18F-FDG could be useful in the evaluation of local and distant disease in-volvement at the staging, in the detection of disease recurrence, and in the evaluation of the response after chemotherapy and/or radio-the-rapy